Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer

CHIA-LIN HSUTZU-HSIU TSAICHUN-KAI HUANGCHING-YAO YANGWEI-YU LIAOCHAO-CHI HOSHENG-YUAN RUANKUAN-YU CHENJIN-YUAN SHIHPAN-CHYR YANG2021-05-052021-05-052021-04-1801695002https://scholars.lib.ntu.edu.tw/handle/123456789/559443Circulating tumor cells (CTCs) are associated with tumor spread, whereas cancer stem cells may be related to drug resistance. However, few studies have analyzed the levels of circulating cancer stem cells (CCSCs) and CTCs in patients with advanced non-small cell lung cancer (NSCLC).enCancer stem cells; Circulating tumor cell; Epidermal growth factor receptor tyrosine kinase inhibitor; Lung cancer; Progression free survival[SDGs]SDG3EGFR protein, human; epidermal growth factor receptor; protein kinase inhibitor; vimentin; cancer stem cell; cell count; genetics; human; lung tumor; mutation; non small cell lung cancer; tumor embolism; Carcinoma, Non-Small-Cell Lung; Cell Count; ErbB ReMonitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancerjournal article10.1016/j.lungcan.2021.04.014338944942-s2.0-85104373844https://scholars.lib.ntu.edu.tw/handle/123456789/558800